A phase I clinical and pharmacokinetic study of the camptothecin glycoconjugate, BAY 38-3441, as a daily infusion in patients with advanced solid tumors
Mross, K.Volume:
15
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdh313
Date:
August, 2004
File:
PDF, 160 KB
english, 2004